Exotropin

Exotropin sells a tightly edited line of neuro-cosmetic topicals sold under the “Exotropin” label: night serums, adaptive moisturizers, and precision eye gels that pair high-dose neuropeptides with post-biotic actives. Prices sit in the premium tier—USD 140–220 per 30 ml unit—and every SKU is released in limited, numbered micro-batches. Distribution is direct-to-consumer through exoceuticals.com only; no third-party e-tailers or brick-and-mortar stockists carry the line. The brand positions itself as “exo-endocrine skincare,” formulating for the skin–brain axis rather than surface correction alone. Its star SKU, the 0.75 % Syn-Tropin™ Night Signal Serum, is the first cosmetic to use a stabilized fragment of MSH-inhibiting peptide ST-Δ4, claiming to down-regulate cortisol-induced aging markers within 6 h of application. All formulas are made under cGMP pharmaceutical conditions in southern California, with blockchain-verified cold-chain shipping that keeps peptide activity above 95 % on delivery. Core buyers are 28-45-year-old professionals in tech, finance, and creative fields who track HRV scores, use continuous-glucose monitors, and want skincare that syncs with bio-optimization routines. They value quantified efficacy over clean-beauty storytelling and are willing to pre-order months ahead if third-party ex-vivo data is supplied. Exotropin competes in the emerging “neuro-cosmetic” space against brands pushing adaptogenic or stress-response skin claims. It differentiates by using pharmaceutical-grade peptides at drug-like concentrations, publishing raw lab data alongside each batch, and refusing influencer markup—keeping per-gram cost of actives 3–4× higher than category averages while maintaining luxury pricing.